ARGX — argenx SE stock price, charts and financials

QT58argenx SE

argenx SE (NASDAQ: ARGX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
844.50
+13.71+1.65%
OverviewShort InterestFilings
ARGXQT58argenx SE·NASDAQ
844.50+1.65%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 20266-KForeign issuer report
Jul 28, 2026SC TO-CSC TO-C
Jul 27, 2026SC TO-CSC TO-C
Jul 27, 20266-KForeign issuer report
Jul 23, 20266-KForeign issuer report
Jun 23, 20266-KForeign issuer report
Jun 03, 20266-KForeign issuer report
May 11, 20266-KForeign issuer report
May 07, 20266-KForeign issuer report
May 06, 20266-KForeign issuer report
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 20, 20266-KForeign issuer report
Mar 20, 20266-KForeign issuer report
Mar 19, 20266-KForeign issuer report
Mar 19, 202620-FAnnual report (foreign issuers)
Mar 06, 20266-KForeign issuer report
Feb 26, 20266-KForeign issuer report
Feb 26, 20266-KForeign issuer report
Jan 13, 20266-KForeign issuer report
Jan 12, 20266-KForeign issuer report
Jan 05, 20266-KForeign issuer report
Dec 17, 2025S-8Registration of employee benefit securities
Dec 15, 20256-KForeign issuer report
Nov 18, 20256-KForeign issuer report
Nov 14, 2025SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 135
Page
▼
/ 6